# Fortress Biotech, Inc.: Form SC 13D/A, filed Feb 14, 2023

- Company: [Fortress Biotech, Inc.](/companies/fbio.md) (CIK 1429260)
- Form: SC 13D/A
- Filed: 2023-02-14
- Accepted by EDGAR: Feb 14, 2023, 16:35 ET
- Period: not reported
- Accession: 0001104659-23-021744
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1429260/000110465923021744/tm236698d1_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1429260/000110465923021744/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1429260/000110465923021744/tm236698d1_sc13da.htm

Filed Feb 14, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-021744. Last ingested by Listed: Nov 14, 2026, 11:27 ET. No prices; not investment advice.
